Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiplatelet therapy

R W Sloan

    American Family Physician
    |October 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Platelet function abnormalities are linked to atherosclerosis and thromboembolic disorders. Understanding platelet aggregation triggers and inhibitors informs the use of antiplatelet agents like aspirin.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Aminoglycosides: once-daily dosing regimen.

    American family physician·1996
    Same author

    Principles of drug therapy in geriatric patients.

    American family physician·1992
    Same author

    Alternative first-line therapies in geriatric hypertension.

    Geriatrics·1989
    Same author

    Atrial fibrillation.

    The Journal of family practice·1986
    Same author

    Digitalis glycosides.

    American family physician·1983
    Same author

    Type I Hyperlipidemia.

    American family physician·1983
    Same journal

    For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

    American family physician·2026
    Same journal

    Nausea and Vomiting During Pregnancy.

    American family physician·2026
    Same journal

    Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

    American family physician·2026
    Same journal

    Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

    American family physician·2026
    Same journal

    Overscreening Leads to Overdiagnosis of MASLD.

    American family physician·2026
    Same journal

    Type 2 Diabetes: Outpatient Insulin Management.

    American family physician·2026
    See all related articles

    Area of Science:

    • Cardiovascular Science
    • Hematology
    • Pharmacology

    Background:

    • Platelets play a critical role in hemostasis and thrombosis.
    • Abnormal platelet function is implicated in the pathophysiology of atherosclerosis and thromboembolic disorders.

    Purpose of the Study:

    • To review current knowledge on platelet morphology, biochemistry, and function.
    • To explore the relationship between platelet function and cardiovascular diseases.
    • To discuss antiplatelet agents used in managing these conditions.

    Main Methods:

    • Literature review of platelet biology and pathophysiology.
    • Analysis of factors influencing platelet aggregation.
    • Overview of current antiplatelet therapies and their indications.

    Related Experiment Videos

    Main Results:

    • Platelet aggregation is promoted by endothelial damage, thromboxane A2, thrombin, adenosine diphosphate, and epinephrine.
    • Prostacyclin is an inhibitor of platelet aggregation.
    • Several antiplatelet agents, including aspirin, sulfinpyrazone, and dipyridamole, are available.

    Conclusions:

    • Understanding platelet function is crucial for diagnosing and treating cardiovascular and thromboembolic diseases.
    • Targeting platelet aggregation pathways offers therapeutic strategies.
    • Further research is needed to refine indications for antiplatelet agent selection.